drugset / Trial / NCT05239598
Povidone-Iodine Oral Rinse Study
RandomizedParallel-groupTriple-blindPrevention
Summary
This study is a two-arm, randomized, 2-phase study. Phase I will be double blinded clinical trial of the safety and efficacy of an antiseptic mouthwash solution on reducing SARS-CoV-2 load in COVID 19+ adult individuals. Phase II is designed as an open label trial, and all subjects will receive the active mouthwash.
Timeline
- Start
- 2022-02-07
- Primary completion
- 2022-07-07
- Completion
- 2022-07-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Povidone-Iodine | Other / unclassified | 10 ml | Other |